Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor

This publication has 70 references indexed in Scilit:

• Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
  New England Journal of Medicine, 2013
• Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
  New England Journal of Medicine, 2011
• Safer CARS
  Molecular Therapy, 2010
• Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical Trial
  Molecular Therapy, 2010
• Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
  Molecular Therapy, 2010
• Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method
  Cancer Gene Therapy, 2009
• Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
  Molecular Therapy, 2009
• Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
  Proceedings of the National Academy of Sciences, 2009
• Chimeric Receptor mRNA Transfection as a Tool to Generate Antineoplastic Lymphocytes
  Human Gene Therapy, 2009
• Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
  Nature Medicine, 2008